VCEL Vericel Corp

Price (delayed)

$57.48

Market cap

$2.93B

P/E Ratio

87.09

Dividend/share

N/A

EPS

$0.66

Enterprise value

$2.89B

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 78

Vericel is a leading provider of advanced therapies for the sports medicine and severe burn care markets. The Company combines innovations in biology with medical technologies, resulting in a highly ...

Highlights
The net income has soared by 155% YoY and by 38% QoQ
The EPS has soared by 154% YoY and by 38% from the previous quarter
The stock's P/E is 3.2% more than its last 4 quarters average of 84.4

Key stats

What are the main financial stats of VCEL

VCEL stock price

How has the Vericel stock price performed over time
Intraday
0.91%
1 week
-1.56%
1 month
43.23%
1 year
44.2%
YTD
59.62%
QTD
43.2%

Financial performance

How have Vericel's revenue and profit performed over time
Revenue
$324.17M
Gross profit
$241.41M
Operating income
$26.97M
Net income
$33.31M
Gross margin
74.5%
Net margin
10.3%
The net income has soared by 155% YoY and by 38% QoQ
The net margin has soared by 102% YoY and by 30% QoQ
Vericel's operating income has increased by 48% QoQ
Vericel's operating margin has increased by 38% from the previous quarter

Price vs fundamentals

How does VCEL's price correlate with its fundamentals

Growth

What is Vericel's growth rate over time

Valuation

What is Vericel stock price valuation
P/E
87.09
P/B
7.66
P/S
9.08
EV/EBIT
83.03
EV/EBITDA
53.59
EV/Sales
8.92
The EPS has soared by 154% YoY and by 38% from the previous quarter
The stock's P/E is 3.2% more than its last 4 quarters average of 84.4
VCEL's price to book (P/B) is 45% higher than its last 4 quarters average of 5.3 and 2.1% higher than its 5-year quarterly average of 7.5
The equity rose by 19% year-on-year and by 3.8% since the previous quarter
VCEL's price to sales (P/S) is 40% higher than its last 4 quarters average of 6.5 and 4.4% higher than its 5-year quarterly average of 8.7
The revenue has grown by 25% YoY and by 6% from the previous quarter

Efficiency

How efficient is Vericel business performance
The ROIC has soared by 137% year-on-year and by 34% since the previous quarter
Vericel's return on assets has surged by 123% YoY and by 34% QoQ
VCEL's ROE has soared by 112% YoY and by 32% from the previous quarter
The ROS has soared by 98% YoY and by 27% from the previous quarter

Dividends

What is VCEL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for VCEL.

Financial health

How did Vericel financials performed over time
The total assets has increased by 14% YoY and by 2.8% QoQ
The quick ratio has increased by 7% year-on-year
The debt is 76% lower than the equity
Vericel's debt to equity has decreased by 20% YoY and by 4% from the previous quarter
The equity rose by 19% year-on-year and by 3.8% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.